End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5 EUR | 0.00% |
|
0.00% | -58.33% |
2023 | Vitruvia Medical AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2022 | Vitruvia Medical AG announced that it expects to receive CHF 2.2 million in funding | CI |
Sales 2021 | 1.97M 2.13M | Sales 2022 | 1.53M 1.65M | Capitalization | 4.07M 4.41M |
---|---|---|---|---|---|
Net income 2021 | -8M -8.67M | Net income 2022 | -1M -1.08M | EV / Sales 2021 | 14.4 x |
Net cash position 2021 | 48.93K 53.02K | Net Debt 2022 | 843K 914K | EV / Sales 2022 | 3.22 x |
P/E ratio 2021 * |
-
| P/E ratio 2022 |
-2.62
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 0% |
1 month | -1.96% | ||
3 months | -50.00% | ||
6 months | -58.33% | ||
Current year | -58.33% |
![Extreme 0.5](/images/extremecours_fleche.png)
![Extreme 0.5](/images/extremecours_fleche.png)
![Extreme 0.2](/images/extremecours_fleche.png)
![Extreme 0.2](/images/extremecours_fleche.png)
![Extreme 0.2](/images/extremecours_fleche.png)
![Extreme 0.2](/images/extremecours_fleche.png)
![Extreme 0.2](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Claus Wiest
CEO | Chief Executive Officer | - | - |
Chairman | - | 17-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | - | 17-10-31 | |
Robert P. Sieber
BRD | Director/Board Member | - | - |
Date | Price | Change |
---|---|---|
24-07-05 | 0.5 | 0.00% |
24-07-04 | 0.5 | 0.00% |
24-07-03 | 0.5 | 0.00% |
24-07-02 | 0.5 | 0.00% |
24-07-01 | 0.5 | 0.00% |
End-of-day quote BOERSE MUENCHEN, July 04, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-58.33% | 1.25M | |
-4.71% | 29.66B | |
+36.58% | 9.22B | |
+32.70% | 4.4B | |
-39.45% | 2.29B | |
-9.44% | 1.6B | |
-29.39% | 1.22B | |
-43.35% | 970M | |
-13.09% | 778M | |
-48.40% | 718M |
- Stock Market
- Equities
- 991 Stock